Source: PR Newswire

Press Release: Global Genomics Group : Global Genomics Group and Datavant Announce Strategic Partnership to Improve Design and Interpretation of Clinical Trials

SAN FRANCISCO and ATLANTA, Jan. 5, 2018 /PRNewswire/ -- Global Genomics Group ("G3"), a precision-medicine-based biopharmaceutical company that leverages large-scale genomic and molecular profiling to develop life-changing diagnostics and therapeutics, and Datavant, a healthcare...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100